Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 11/20 | 0.61 |
| ▸ | TTR | P02766 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.41 |
| ▸ | CDC25A | P30304 | 1/20 | 0.40 |
| ▸ | CDC25C | P30307 | 1/20 | 0.40 |
| ▸ | ADCY1 | Q08828 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23204096 | 0.93 | AHR (0.61) | AHRTTRALDH1A1LMNAKMT2A | |
| SCHEMBL23203617 | 0.90 | AHR (0.62) | AHRTTRALDH1A1LMNACDC25A | |
| SCHEMBL8128583 | 0.86 | AHR (0.73) | AHRTTRALDH1A1LMNAKMT2A | |
| SCHEMBL22703059 | 0.85 | AHR (0.54) | AHRTTRALDH1A1LMNAKMT2A | |
| SCHEMBL24268388 | 0.82 | AHR (0.79) | AHRTTRALDH1A1LMNAKMT2A | |
| SCHEMBL24564907 | 0.82 | MAPT (0.50) | AHRALDH1A1LMNAKMT2AKDM4E | |
| SCHEMBL2282515 | 0.82 | AHR (0.78) | AHRTTRALDH1A1LMNAKMT2A | |
| SCHEMBL21651125 | 0.78 | AHR (0.61) | AHRTTRALDH1A1LMNAKMT2A | |
| SCHEMBL10646422 | 0.78 | KDM4E (0.67) | AHRTTRALDH1A1LMNAKDM4E | |
| SCHEMBL29591806 | 0.78 | AHR (0.61) | AHRTTRALDH1A1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873297-B2 | Compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| WO-2022025714-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2022-02-03 | — | — | WO | disclosed |
| WO-2020022779-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2020-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873297-B2 | Compound and organic light emitting device comprising the same | CCNL2, UBE2L3, ARL1 | AHR 44/4885TTR 4313/4885ALDH1A1 1548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.